BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2021 8:44:04 AM | Browse: 456 | Download: 1191
 |
Received |
|
2021-07-04 03:22 |
|
Peer-Review Started |
|
2021-07-04 03:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-26 10:15 |
|
Revised |
|
2021-07-26 16:58 |
|
Second Decision |
|
2021-09-09 03:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-09-10 09:14 |
|
Articles in Press |
|
2021-09-10 09:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-10-17 15:15 |
|
Publish the Manuscript Online |
|
2021-10-21 08:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Panot Sainamthip, Chutcharn Kongphanich, Naiyarat Prasongsook and Sakkarin Chirapongsathorn |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sakkarin Chirapongsathorn, MD, MSc, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, Phramongkutklao College of Medicine, 315 Rajvithee, Jatujak 10900, Thailand. sakkarin.chi@pcm.ac.th |
| Key Words |
Hepatocellular carcinoma; Chemoembolization; Dexamethasone; Double blind method; Prevention; Postembolization syndrome |
| Core Tip |
Even in the immuno-oncology era, transcatheter arterial chemoembolisation (TACE) is the most effective way to treat intermediate stage hepatocellular carcinoma. Postembolisation syndrome (PES) is the most common side effect from TACE and there is still no standard prevention guideline. In the present study we report the method to prevent PES, the most common adverse event after TACE in intermediate stage hepatocellular carcinoma patients, by using single dose dexamethasone. |
| Publish Date |
2021-10-21 08:44 |
| Citation |
Sainamthip P, Kongphanich C, Prasongsook N, Chirapongsathorn S. Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study. World J Clin Cases 2021; 9(30): 9059-9069 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i30/9059.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i30.9059 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
